These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38727811)

  • 1. Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients.
    Igbo BT; Jentsch C; Linge A; Plesca I; Kuzay Y; Löck S; Kumaravadivel MS; Doms S; Stolz-Kieslich L; Pollack D; Brückmann S; Tittlbach H; Weitz J; Aust D; Apolle R; Schmitz M; Troost EGC
    Strahlenther Onkol; 2024 Jul; 200(7):595-604. PubMed ID: 38727811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma.
    Igbo BT; Linge A; Frosch S; Suckert T; Stolz-Kieslich L; Löck S; Kumaravadivel MS; Welsch T; Weitz J; Sommer U; Aust D; Troost EGC
    Clin Transl Radiat Oncol; 2022 Sep; 36():106-112. PubMed ID: 35993091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer.
    Machiels M; van Montfoort ML; Thuijs NB; van Berge Henegouwen MI; Alderliesten T; Meijer SL; van Hooft JE; Hulshof MCCM
    Radiat Oncol; 2019 Dec; 14(1):219. PubMed ID: 31801574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas.
    Oliveira-Costa JP; Zanetti JS; Silveira GG; Soave DF; Oliveira LR; Zorgetto VA; Soares FA; Zucoloto S; Ribeiro-Silva A
    Diagn Pathol; 2011 Aug; 6():73. PubMed ID: 21824412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Still proliferating CD44
    Klose J; Schmitt A; Pernthaler J; Warschkow R; Büchler MW; Schneider M; Lasitschka F; Tarantino I
    Eur J Surg Oncol; 2021 Aug; 47(8):2078-2086. PubMed ID: 33814238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy.
    Koda M; Kanczuga-Koda L; Sulkowska M; Surmacz E; Sulkowski S
    BMC Cancer; 2010 Jun; 10():320. PubMed ID: 20569445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial.
    Kartini D; Taher A; Panigoro SS; Setiabudy R; Jusman SW; Haryana SM; Abdullah M; Rustamadji P; Purwanto DJ; Sutandyo N; Suroyo I; Siregar BH; Maruli H; Sungkar S
    J Egypt Natl Canc Inst; 2020 Feb; 32(1):12. PubMed ID: 32372215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
    Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
    Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients.
    Zhang L; Ye SB; Li ZL; Ma G; Chen SP; He J; Liu WL; Xie D; Zeng YX; Li J
    Int J Clin Exp Pathol; 2014; 7(7):3887-97. PubMed ID: 25120765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.
    Ji F; Wang Y; Qiu L; Li S; Zhu J; Liang Z; Wan Y; Di W
    Int J Oncol; 2013 May; 42(5):1578-88. PubMed ID: 23545606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of hypoxia-inducible factor 1α, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma.
    Shao N; Han Y; Song L; Song W
    J Cancer Res Ther; 2020; 16(2):269-275. PubMed ID: 32474512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma.
    Yang Z; Ni W; Cui C; Qi W; Piao L; Xuan Y
    Hum Pathol; 2018 Nov; 81():148-156. PubMed ID: 30031102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
    Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
    JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic markers in stage I oral cavity squamous cell carcinoma.
    Dunkel J; Vaittinen S; Grénman R; Kinnunen I; Irjala H
    Laryngoscope; 2013 Oct; 123(10):2435-41. PubMed ID: 23918741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between ADC values and molecular markers of Ki-67 and HIF-1α in hepatocellular carcinoma.
    Huang Z; Xu X; Meng X; Hou Z; Liu F; Hua Q; Liu Q; Xiu J
    Eur J Radiol; 2015 Dec; 84(12):2464-9. PubMed ID: 26456310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer.
    Sohda M; Ishikawa H; Masuda N; Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Fukai Y; Sakurai H; Kuwano H
    Int J Cancer; 2004 Jul; 110(6):838-44. PubMed ID: 15170665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-associated markers in gastric carcinogenesis and HIF-2alpha in gastric and gastro-oesophageal cancer prognosis.
    Griffiths EA; Pritchard SA; McGrath SM; Valentine HR; Price PM; Welch IM; West CM
    Br J Cancer; 2008 Mar; 98(5):965-73. PubMed ID: 18283323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer.
    Qin R; Smyrk TC; Reed NR; Schmidt RL; Schnelldorfer T; Chari ST; Petersen GM; Tang AH
    Br J Cancer; 2015 Feb; 112(3):514-22. PubMed ID: 25584484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
    Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
    de Andrade Barreto E; de Souza Santos PT; Bergmann A; de Oliveira IM; Wernersbach Pinto L; Blanco T; Rossini A; Pinto Kruel CD; Mattos Albano R; Ribeiro Pinto LF
    Exp Mol Pathol; 2016 Aug; 101(1):66-73. PubMed ID: 27260309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.